[
  {
    "ts": null,
    "headline": "Gilead Sciences: Dividend Investors Must Be Cautious",
    "summary": "Gilead Sciences offers steady dividend growth with a 2.99% yield. Read why the analyst nonetheless has a neutral rating on the stock.",
    "url": "https://finnhub.io/api/news?id=7d2b24c83ba1a84896164372fbaeda3eb377015fa61aa6575396ae259593122c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745766903,
      "headline": "Gilead Sciences: Dividend Investors Must Be Cautious",
      "id": 134108455,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1189813806/image_1189813806.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Gilead Sciences offers steady dividend growth with a 2.99% yield. Read why the analyst nonetheless has a neutral rating on the stock.",
      "url": "https://finnhub.io/api/news?id=7d2b24c83ba1a84896164372fbaeda3eb377015fa61aa6575396ae259593122c"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks",
    "summary": "As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor concerns.",
    "url": "https://finnhub.io/api/news?id=a7b86d481014d6d18633c5e47f4a166c1806e4c71992a1314cb2756118891ef1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745751600,
      "headline": "Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks",
      "id": 134107528,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor concerns.",
      "url": "https://finnhub.io/api/news?id=a7b86d481014d6d18633c5e47f4a166c1806e4c71992a1314cb2756118891ef1"
    }
  }
]